## **What is an unclassified biologic?**
J3590 is a HCPCS level II unlisted codes descriptor used to bill drugs and biologicals that do not yet have a specific HCPCS code. These may be newly approved biologics, off-label uses, patient-specific preparations, or a compounded drug without a unique identifier. Because it is a catch-all NOC drug, payers expect detailed support before payment.
Correct use begins with clear identification (brand/generic), National Drug Code, strength, dose, route, and clinical rationale; pair the drug with the appropriate administration injection code for the encounter. Until an appropriate HCPCS code (or other specific code) is assigned, J3590 enables claims submission under payer billing guidelines when you provide “such information” needed for review.
## **J3590 documentation requirements**
Thorough documentation is essential for review and adjudication when billing J3590. Include:
### **Product identification**
List brand/generic, formulation, strength, and National Drug Code (NDC). Keep the purchase acquisition cost invoice available for auditor or payer requests.
### **Clinical indication and necessity**
Document diagnosis, prior therapies attempted/failed, and why no valid HCPCS code or specific HCPCS code exists yet for the product, formulation, or indication.
### **Dose and administration**
Record total dose, units, concentration, and route (e.g., IV, SC), plus start/stop times if infused. Identify the related injection code used for the visit.
### **Lot, vial, and wastage**
Capture lot number, expiration date, container type, and any drug wastage with administered vs discarded amounts, supported by nursing/pharmacy notes.
### **Claim forms and data standards**
Ensure UB-04/CMS-1500 (or electronic equivalent) is completed per National Uniform Billing Committee standards, and attach any payer-requested details to support correct billing under NOC codes and unlisted drugs.
Many payer manuals include disclaimers about consequential damages arising from errors and other inaccuracies in published materials—verify the most current instructions before submitting.
## **J3590 billing requirements**
Expect manual review. Clean, detailed claims speed decisions and reduce denials.
### **Detailed line description**
Populate the HCPCS line with drug name, strength, dose, route, and NDC so reviewers can confirm no appropriate HCPCS code exists.
### **Units and pricing**
Report exact billable units tied to dose and submit pricing based on the acquisition cost per payer policy; include invoices when requested for correct billing.
### **Modifiers for wastage**
When the product comes in a single-dose container, use JW for discarded amounts and JZ when no discard occurred, consistent with CMS billing guidelines for NOC codes.
### **Authorization and coverage**
Verify Medicare and Medicaid services policies and plan-specific criteria. Some payers require pre-service review for unlisted drugs and NOC codes.
### **Convert when possible**
As soon as a valid or specific HCPCS code is assigned, stop using J3590 and bill the new code for future dates of service.
## **J3590 applicable modifiers**
Use modifiers to reflect wastage status and meet payer policy:
**- JW - Drug amount discarded/not administered**: Required when part of a single-dose container is wasted; bill waste on a separate line.
**- JZ - Zero drug wasted:** Required (Medicare and many payers) when no wastage occurred from a single-dose container.
**- RT / LT / 50 - Site modifiers:** Indicate right, left, or bilateral administration when the clinical context requires side designation.
**- JG / TB - 340B informational modifiers:** Identify 340B-acquired items; informational for Medicare OPPS unless payer policy states otherwise.
**- 99 - Multiple modifiers (if needed):** Use when a payer requires more than one modifier on the same line.
Note: J3590 describes the drug; select the appropriate administration injection code (e.g., 96372 therapeutic injection; 96413 chemotherapy infusion) based on the service performed.
## **Other relevant codes**
When J3590 is not appropriate—or the care setting differs—review these related HCPCS options (verify payer policies and status):
- C9399 – Unclassified drugs or biologics (OPPS hospital outpatient use).
- J3490 – Unclassified drugs (non-biologic medications without a code).
- J9999 – Antineoplastic drugs not otherwise classified (oncology use when no code exists).
- J7999 – Compounded drug, not otherwise classified (when the preparation is compounded).
Frequently asked questions
